1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Armored CAR T-cells: Utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
    Journal Article

    Yeku, O. O.; Brentjens, R. J.
    Biochemical Society Transactions (2016)

    Fulltext@MSK | Save
  • Success of an international learning health care system in hematopoietic cell transplantation: The American Society of Blood and Marrow Transplantation Clinical Case Forum
    Journal Article

    Barba, P.; Burns, L. J.; Litzow, M. R.; Juckett, M. B.; Komanduri, K. V.; Lee, S. J.; Devlin, S. M.; Costa, L. J.; Khan, S.; King, A.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Manipulating the immune system with checkpoint inhibitors for patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.
    American Society of Clinical Oncology Educational Book (2016)

    Fulltext@MSK | Save
  • Final phase IIa study results evaluating the CXCR4 antagonist BL-8040 in combination with cytarabine (Ara-C) for the treatment of relapsed/refractory AML patients
    Meeting Abstract

    Borthakur, G.; Tallman, M.; Ofran, Y.; Foran, J.; Uy, G.; DiPersio, J.; Nagler, A.; Rowe, J.; Showel, M.; Altman, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • A chart review of lower dosing of ponatinib in patients with chronic myeloid leukemia (CML): Preliminary findings
    Meeting Abstract

    Mauro, M.; McGarry, L.; Inguilizian, A.; du Moulin, R.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • The PACE clinical trial vs the real-world: Comparison of ponatinib prescribing and duration of therapy in chronic-phase chronic myeloid leukemia (CP-CML) patients
    Meeting Abstract

    Mauro, M.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Rapid achievement of MR(4.5) after switching from imatinib to nilotinib in patients with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
    Meeting Abstract

    Ritchie, E.; Deininger, M.; Erba, H.; Savona, M.; Paley, C.; Dautaj, I.; Mauro, M.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Phase I trial: CD19-targeted CAR T-cells in patients with residual CLL following initial purine analog-based therapy
    Meeting Abstract

    Geyer, M.; Park, J.; RivieĢ€re, I.; Senechal, B.; Hsu, M.; Wang, X.; Purdon, T.; Sadelain, M.; Brentjens, R.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Ponatinib therapy for Philadelphia-positive ALL (Ph+ ALL) patients: Real-world clinical practice vs the PACE trial
    Meeting Abstract

    Mauro, M.; McGarry, L.; Yang, M.; Lustgarten, S.; Huang, H.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Meeting Abstract

    Mathias, M.; Sockolosky, J.; Chang, A.; Liu, C.; Garcia, K.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save